Annotated Bibliography
1) Mach M, Stamminger T, Jahn G, Human Cytomegalovirus: Recent Aspects from Molecular Biology, J. gen. Virol.,1989;70:3117-3146.
2) Stegmann BJ, Carey JC, TORCH Infections. Toxoplasmosis, Other (syphilis, varicella-zoster, parvovirus B19), Rubella, Cytomegalovirus (CMV), and Herpes infections, Curr Womens Health Rep. 2002;2(4):253-8.
3) Staras SAS, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ: Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clin Infect Dis 2006, 43(9):1143-1151.
4) Hodinka RL, Friedman HM,Human Cytomegalovirus, in: Balows A (ed), Manuel of Clinical Microbiology, 5’th ed, Washington: American Society for Microbiology, 1991, pp: 829-36.
5) Adler SP, Transfusion-associated cytomegalovirus infections. Review oflnfeetious Diseases 5, 1983:977-993
6) Mandell GL, Bennett JE, Dolin R., Principles and practice of infectious diseases, 5th ed. Philadelphia: Churchill Livingstone, 2000: 1586-96.
7) Arne B Brantsaeter, Mona Holberg-Petersen, Stig Jeansson, Anne K Goplen and Johan N Bruun, CMV quantitative PCR in the diagnosis of CMV disease in patients with HIV-infection – a retrospective autopsy based study, BMC Infectious Diseases 2007, 7:127